Characteristics | TACE (n = 28) | TACE + MWA (n = 23) | P value |
---|---|---|---|
Age | 52 (34–65) | 56 (36–69) | 0.231b |
Sex | 0.842a | ||
 Male | 19 (68%) | 15 (65%) | |
 Female | 9 (32%) | 8 (35%) | |
ECOG performance status | 1.00c | ||
 0 | 25 (89%) | 21 (91%) | |
 1 | 3 (11%) | 2 (9%) | |
Etiology | 0.487c | ||
 Hepatitis B | 4 (14%) | 1 (4%) | |
 Hepatitis C | 16 (57%) | 13 (57%) | |
 Alcohol | 7 (25%) | 6 (26%) | |
 Unknown | 1 (4%) | 3 (13%) | |
Child–Pugh class | 0.802a | ||
 A | 18 (64%) | 14 (61%) | |
 B | 10 (36%) | 9 (39%) | |
Vascular invasion | |||
 Portal vein (2nd or 3rd order) | 2 (7%) | 1 (4%) | |
 Hepatic vein | 0 | 0 | |
AFP level | 26.6 (2.9–655.2) | 45.3 (4.2–876.7) | 0.352 |
Tumor number | 0.336c | ||
 Single | 16 (57%) | 8 (35%) | |
 2 | 9 (32%) | 10 (43%) | |
 3 | 3 (11%) | 4 (17%) | |
  > 3 | 0 | 1 (5%) | |
Tumor diameter | 0.254a | ||
  < 3 | 9 (32%) | 11 (48%) | |
 3⩾,< 5 | 19 (68%) | 12 (32%) | |
Tumor location in liver | 0.939a | ||
 Right lobe | 6 (21%) | 4 (17%) | |
 Left lobe | 12 (43%) | 10 (43%) | |
 Both lobes | 10 (36%) | 9 (39%) |